These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38488259)

  • 1. Sodium iodide symporter immunolabelling as a predictor of clinical iodide uptake in canine thyroid carcinoma: A preliminary study.
    Dark KV; Skinner OT; Kim DY; Karnia JJ; Mickelson MA; Maitz CA
    Vet Comp Oncol; 2024 Jun; 22(2):239-244. PubMed ID: 38488259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine follicular cell and medullary thyroid carcinomas: Immunohistochemical characterization.
    Jankovic J; Tièche E; Dettwiler M; Hahn K; Scheemaeker S; Kessler M; Daminet S; Rottenberg S; Campos M
    Vet Pathol; 2024 Jul; 61(4):524-533. PubMed ID: 38098215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
    Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
    Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
    Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
    Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
    Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of sodium/iodide symporter (NIS) for thyroid cancer management.
    Carvalho DP; Ferreira AC
    Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):672-82. PubMed ID: 17891230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo.
    Zuckier LS; Dohan O; Li Y; Chang CJ; Carrasco N; Dadachova E
    J Nucl Med; 2004 Mar; 45(3):500-7. PubMed ID: 15001694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation and tissue distribution of the human sodium iodide symporter gene.
    Ajjan RA; Kamaruddin NA; Crisp M; Watson PF; Ludgate M; Weetman AP
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):517-23. PubMed ID: 9876351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers.
    Peyrottes I; Navarro V; Ondo-Mendez A; Marcellin D; Bellanger L; Marsault R; Lindenthal S; Ettore F; Darcourt J; Pourcher T
    Eur J Endocrinol; 2009 Feb; 160(2):215-25. PubMed ID: 19029227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
    Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
    Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of Immunohistochemistry for Canine Proteins Involved in Thyroid Iodine Uptake and Their Expression in Canine Follicular Cell Thyroid Carcinomas (FTCs) and FTC-Derived Organoids.
    Jankovic J; Dettwiler M; Fernández MG; Tièche E; Hahn K; April-Monn S; Dettmer MS; Kessler M; Rottenberg S; Campos M
    Vet Pathol; 2021 Nov; 58(6):1172-1180. PubMed ID: 34056980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.
    Ravera S; Reyna-Neyra A; Ferrandino G; Amzel LM; Carrasco N
    Annu Rev Physiol; 2017 Feb; 79():261-289. PubMed ID: 28192058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
    Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
    J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of Na+/I- symporter in thyroid cancers in an iodine-deficient population: an immunohistochemical study.
    Mishra A; Pal L; Mishra SK
    World J Surg; 2007 Sep; 31(9):1737-1742. PubMed ID: 17653791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Tyrosine Kinase Inhibitor Can Augment Radioactive Iodine Uptake Through Endogenous Sodium/Iodide Symporter Expression in Anaplastic Thyroid Cancer.
    Oh JM; Baek SH; Gangadaran P; Hong CM; Rajendran RL; Lee HW; Zhu L; Gopal A; Kalimuthu S; Jeong SY; Lee SW; Lee J; Ahn BC
    Thyroid; 2020 Apr; 30(4):501-518. PubMed ID: 31928162
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake.
    Castro MR; Bergert ER; Goellner JR; Hay ID; Morris JC
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5627-32. PubMed ID: 11701745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The practical relevance of the sodium iodide symporter].
    Spitzweg C
    Z Arztl Fortbild Qualitatssich; 2004 May; 98 Suppl 5():25-32. PubMed ID: 15255310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium/iodide-symporter: distribution in different mammals and role in entero-thyroid circulation of iodide.
    Josefsson M; Grunditz T; Ohlsson T; Ekblad E
    Acta Physiol Scand; 2002 Jun; 175(2):129-37. PubMed ID: 12028133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium iodide symporter: its role in nuclear medicine.
    Chung JK
    J Nucl Med; 2002 Sep; 43(9):1188-200. PubMed ID: 12215558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [
    Jiang H; DeGrado TR
    Theranostics; 2018; 8(14):3918-3931. PubMed ID: 30083270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.